These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 166095)
1. Inorganic pyrophosphate pool size and turnover rate in arthritic joints. Camerlain M; McCarty DJ; Silcox DC; Jung A J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095 [TBL] [Abstract][Full Text] [Related]
2. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. Park W; Masuda I; Cardenal-Escarcena A; Palmer DL; McCarty DJ J Rheumatol; 1996 Apr; 23(4):665-71. PubMed ID: 8730124 [TBL] [Abstract][Full Text] [Related]
3. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Hirose J; Ryan LM; Masuda I Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726 [TBL] [Abstract][Full Text] [Related]
4. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. Bennett RM; Lehr JR; McCarty DJ J Clin Invest; 1975 Dec; 56(6):1571-9. PubMed ID: 423 [TBL] [Abstract][Full Text] [Related]
5. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints. Pattrick M; Hamilton E; Hornby J; Doherty M Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409 [TBL] [Abstract][Full Text] [Related]
6. Synovial fluid calcium pyrophosphate dihydrate crystals and alizarin red positivity: analysis of 3000 samples. Hamilton E; Pattrick M; Hornby J; Derrick G; Doherty M Br J Rheumatol; 1990 Apr; 29(2):101-4. PubMed ID: 2157516 [TBL] [Abstract][Full Text] [Related]
7. Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia. Silcox DC; McCarty DJ J Clin Invest; 1973 Aug; 52(8):1863-70. PubMed ID: 4352576 [TBL] [Abstract][Full Text] [Related]
8. Soluble E-selectin is increased in inflammatory synovial fluid. Carson CW; Beall LD; Hunder GG; Johnson CM; Newman W J Rheumatol; 1994 Apr; 21(4):605-11. PubMed ID: 7518520 [TBL] [Abstract][Full Text] [Related]
9. Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis. Fam AG; Schumacher HR; Clayburne G; Villanueva T; Baker D; Jimenez SA J Rheumatol; 1990 May; 17(5):644-55. PubMed ID: 2162961 [TBL] [Abstract][Full Text] [Related]
10. [Identification of crystals in synovial fluid: joint-specific identification rate and correlation with clinical preliminary diagnosis]. Schlapbach P; Pfluger D; Gerber NJ Schweiz Med Wochenschr; 1992 Jun; 122(25):969-74. PubMed ID: 1621079 [TBL] [Abstract][Full Text] [Related]
11. Citrate in synovial fluid and its relation to inflammation and crystal presence. Van Linthoudt D; Salani I; Zender R; Locatelli P; Ott H; Schumacher HR J Rheumatol; 1996 Mar; 23(3):502-5. PubMed ID: 8832992 [TBL] [Abstract][Full Text] [Related]
12. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412 [TBL] [Abstract][Full Text] [Related]
13. Inorganic pyrophosphate metabolism in arthritis. Rachow JW; Ryan LM Rheum Dis Clin North Am; 1988 Aug; 14(2):289-302. PubMed ID: 2845490 [TBL] [Abstract][Full Text] [Related]
14. [Serum keratan sulfate studies and their significance in the evaluation of cartilage degradation in degenerative and inflammatory joint diseases]. Sárközi AM; Hámori G; Fülöp C; Búzás E; Brózik M; Merétey K; Glant TT Orv Hetil; 1993 Feb; 134(9):461-7. PubMed ID: 8446416 [TBL] [Abstract][Full Text] [Related]
15. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Martínez Sanchis A; Pascual E Ann Rheum Dis; 2005 Dec; 64(12):1769-72. PubMed ID: 15941838 [TBL] [Abstract][Full Text] [Related]
16. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis. Doherty M; Belcher C; Regan M; Jones A; Ledingham J Ann Rheum Dis; 1996 Jul; 55(7):432-6. PubMed ID: 8774160 [TBL] [Abstract][Full Text] [Related]
17. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout. Silcox DC; McCarty DJ J Lab Clin Med; 1974 Apr; 83(4):518-31. PubMed ID: 4361744 [No Abstract] [Full Text] [Related]
18. Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis. Rovensky J; Imrich R; Radikova Z; Simorova E; Greguska O; Vigas M; Macho L Endocr Regul; 2005 Jan; 39(1):1-6. PubMed ID: 16107132 [TBL] [Abstract][Full Text] [Related]
19. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054 [TBL] [Abstract][Full Text] [Related]
20. Extrusion of pyrophosphate into extracellular media by osteoarthritic cartilage incubates. Howell DS; Muniz O; Pita JC; Enis JE J Clin Invest; 1975 Dec; 56(6):1473-80. PubMed ID: 172532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]